Botulinum Toxin Injection for Intractable Pain in Cancer Patients With Psoas Muscle Invasion.

J Pain Symptom Manage

Department of Rehabilitation Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea. Electronic address:

Published: April 2022

Muscle invasion (MI) in patients with far-advanced cancer is often accompanied with pain. Conventional treatments used for pain relief may be associated with several side effects. We describe two cases of botulinum toxin injection (BTI) for relieving intractable pain in patients of far-advanced cancer having MI. The patients presented with persistent intractable pain that did not respond to conventional treatments, such as analgesic medications, epidural steroid injection, and radiotherapy. BTI relieved the intractable pain in these cases for at least 9-12 weeks without any reported side effects. We suggest that BTI can be an alternative method to relieve intractable pain associated with MI in patients with far-advanced cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2021.11.014DOI Listing

Publication Analysis

Top Keywords

intractable pain
20
patients far-advanced
12
far-advanced cancer
12
botulinum toxin
8
toxin injection
8
cancer patients
8
muscle invasion
8
conventional treatments
8
side effects
8
pain
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!